Cases - Charles Bonnet syndrome: Visual loss and hallucinations

CMAJ. Canadian Medical Association Journal

Volumn 181, Issue 3-4, 2009, Pages 175-176

  Jackson, M L ^a   Ferencz, Joseph ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; DUTASTERIDE; RANIBIZUMAB; TAMSULOSIN;

AGED; ARTICLE; CASE REPORT; CHARLES BONNET SYNDROME; CLINICAL FEATURE; COGNITION; GOUT; HUMAN; MALE; PROSTATE HYPERTROPHY; RETINA MACULA AGE RELATED DEGENERATION; VISION; VISUAL ACUITY; VISUAL HALLUCINATION; VISUAL IMPAIRMENT;

EID: 68549128980     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.090049     Document Type: Article

References (16)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Arlington (VA): The Association; 1994.
2. Jackson ML, Bassett K, Nirmalan PV, et al. Contrast sensitivity and visual hallucinations in patients referred to a low vision rehabilitation clinic. Br J Ophthalmol 2007;91:296-8.
3. Menon GJ, Rahman I, Menon SJ, et al. Complex visual hallucinations in the isually impaired: the Charles Bonnet syndrome. Surv Ophthalmol 2003;48:58-72.
4. Hori H, Terao T, Nakamura J. Charles Bonnet syndrome with auditory hallucinations: a diagnostic dilemma. Psychopathology 2001;34:164-6.
5. Fernandez A, Lichtshein G, Vieweg V. The Charles Bonnet syndrome: a review. J Nerv Ment Dis 1997;185:195-200.
6. Merabet LB, Maguire D, Warde A, et al. Visual hallucinations during prolonged blindfolding in sighted subjects. J Neuroophthalmol 2004;24:109-13.
7. Biousse V, Skibell BC, Wattts R, et al. Ophthalmologic features of Parkinson's disease. Neurology 2004;62:177-80.
8. Holroyd S, Rabins PV. A three-year follow-up study of visual hallucinations in patients with macular degeneration. J Nerv Ment Dis 1996;184:188-9.
9. Howard R, Meehan O, Powell R, et al. Successful treatment of Charles Bonnet syndrome type visual hallucinosis with low dose risperidone. Int J Geriatr Psychiatry 1994;9:677-8.
10. Ranen NG, Pasternak RE, Rovern BW. Cisapride in the treatment of visual hallucinations caused by visual loss: the Charles Bonnet syndrome. Am J Geriatr Psychiatry 1999;7:264-6.
11. Hori H, Terao T, Shirashi Y, et al. Treatment of Charles Bonnet syndrome with valproate. Int Clin Psychopharmacol 2000;15:117-9.
12. Terao T. Effect of carbamazepine and clonazepam combinationon on Charles Bonnet syndrome: a case report. Hum Psychopharmacol Clin Exp 1998;13:451-3.
13. Lang UE, Stogowdki D, Schulze D, et al. Charles Bonnet syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors. J Psychopharmacol 2007;21:553-7.
14. Holroyd S, Sabeen S. Successful treatment of hallucinations associated with sensory impairment using gabapentin. J Neuropsychiatry Clin Neurosci 2008;20:364-6.
15. Coletti Moja M, Milano E, Gasverde S, et al. Olanzapine therapy in hallucinatory vision related to Bonnet syndrome. Neurol Sci 2005;26:168-70.
16. Hedges TR Jr. Charles Bonnet, his life, and his syndrome. Surv Ophthalmol 2007;52:111-4.